DIAPH3 governs the cellular transition to the amoeboid tumour phenotype

Therapies for most malignancies are generally ineffective once metastasis occurs. While tumour cells migrate through tissues using diverse strategies, the signalling networks controlling such behaviours in human tumours are poorly understood. Here we define a role for the Diaphanous‐related formin‐3...

Full description

Saved in:
Bibliographic Details
Published inEMBO molecular medicine Vol. 4; no. 8; pp. 743 - 760
Main Authors Hager, Martin H., Morley, Samantha, Bielenberg, Diane R., Gao, Sizhen, Morello, Matteo, Holcomb, Ilona N., Liu, Wennuan, Mouneimne, Ghassan, Demichelis, Francesca, Kim, Jayoung, Solomon, Keith R., Adam, Rosalyn M., Isaacs, William B., Higgs, Henry N., Vessella, Robert L., Di Vizio, Dolores, Freeman, Michael R.
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2012
WILEY‐VCH Verlag
EMBO Press
WILEY-VCH Verlag
Springer Nature
Subjects
Online AccessGet full text
ISSN1757-4676
1757-4684
1757-4684
DOI10.1002/emmm.201200242

Cover

More Information
Summary:Therapies for most malignancies are generally ineffective once metastasis occurs. While tumour cells migrate through tissues using diverse strategies, the signalling networks controlling such behaviours in human tumours are poorly understood. Here we define a role for the Diaphanous‐related formin‐3 (DIAPH3) as a non‐canonical regulator of metastasis that restrains conversion to amoeboid cell behaviour in multiple cancer types. The DIAPH3 locus is close to RB1 , within a narrow consensus region of deletion on chromosome 13q in prostate, breast and hepatocellular carcinomas. DIAPH3 silencing in human carcinoma cells destabilized microtubules and induced defective endocytic trafficking, endosomal accumulation of EGFR, and hyperactivation of EGFR/MEK/ERK signalling. Silencing also evoked amoeboid properties, increased invasion and promoted metastasis in mice. In human tumours, DIAPH3 down‐regulation was associated with aggressive or metastatic disease. DIAPH3‐silenced cells were sensitive to MEK inhibition, but showed reduced sensitivity to EGFR inhibition. These findings have implications for understanding mechanisms of metastasis, and suggest that identifying patients with chromosomal deletions at DIAPH3 may have prognostic value.
Bibliography:These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Present address: R&D Division, Oncology Research Laboratories, Daiichi Sankyo Europe, Munich, Germany
ISSN:1757-4676
1757-4684
1757-4684
DOI:10.1002/emmm.201200242